SCHEMBL29449182

SCHEMBL29449182

CN1CCN(c2ccc(Nc3cc(NCCCN4CCCOCC4=O)c(C(F)(F)F)cn3)cc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ULK1 O75385 1/20 0.53
ULK2 Q8IYT8 1/20 0.53
MAPK9 P45984 4/20 0.47
MAPK10 P53779 4/20 0.47
BRD4 O60885 3/20 0.40
FYN P06241 1/20 0.40
FLT3 P36888 3/20 0.39
PTK2 Q05397 3/20 0.38
EGFR P00533 2/20 0.38
WEE1 P30291 1/20 0.38
CSF1R P07333 1/20 0.37
JAK2 O60674 1/20 0.37
ERBB3 P21860 1/20 0.37
ABL1 P00519 1/20 0.37
BCR P11274 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22634468 1.00 ULK1 (0.53) ULK1ULK2MAPK9MAPK10BRD4
SCHEMBL29449048 0.90 ULK1 (0.52) ULK1ULK2MAPK9MAPK10BRD4
SCHEMBL22634458 0.90 ULK1 (0.52) ULK1ULK2MAPK9MAPK10BRD4
SCHEMBL22652087 0.90 ULK1 (0.65) ULK1ULK2MAPK9MAPK10BRD4
SCHEMBL22634554 0.90 ULK1 (0.53) ULK1ULK2MAPK9MAPK10BRD4
SCHEMBL29448982 0.90 ULK1 (0.53) ULK1ULK2MAPK9MAPK10BRD4
SCHEMBL29449166 0.89 ULK1 (0.49) ULK1ULK2MAPK9MAPK10BRD4
SCHEMBL22634498 0.89 ULK1 (0.49) ULK1ULK2MAPK9MAPK10BRD4
SCHEMBL22634665 0.88 ULK1 (0.42) ULK1ULK2MAPK9MAPK10PTK2
SCHEMBL29449119 0.88 ULK1 (0.42) ULK1ULK2MAPK9MAPK10PTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3966207-A1 PHENYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF Deciphera Pharmaceuticals, LLC (US) 2022-03-16 EP claimed
EP-3966207-A1 PHENYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF Deciphera Pharmaceuticals, LLC (US) 2022-03-16 EP disclosed